BioCentury
ARTICLE | Finance

VelosBio jumps on megaround bandwagon with $137M series B

July 8, 2020 9:54 PM UTC

With its $137 million series B round Wednesday, VelosBio became the 50th biotech this year to raise a venture round topping the $100 million mark (see "Venture Megarounds Tracking to New Record”).

It is also the third biotech to raise a crossover-heavy megaround this month, following Tuesday’s $110 million series B by Vor Biopharma Inc. and last week's $100 million round from Annexon Inc., which has since filed to go public on NASDAQ (see "Annexon Joins Burgeoning IPO Queue”; "Crossovers Pile into Vor Series B”). ...